Medicare Enrolled
Dr. Jyoti Bhat, M.D.
Internal Medicine · Concord, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhat
Dr. Jyoti Bhat is an internal medicine specialist in Concord, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Bhat performed 13,404 Medicare services across 2,426 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhat received a total of $7,582 from 46 pharmaceutical and/or device companies across 329 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 2% volume in CA
$7,582 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,404
Medicare services
Top 2% in CA for internal medicine
2,426
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~788 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,440 | $18 | $49 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,286 | $87 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
745 | $63 | $150 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
717 | $59 | $144 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
568 | $47 | $150 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
528 | $54 | $190 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
273 | $29 | $115 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
214 | $14 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
212 | $120 | $430 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
62 | $38 | $148 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
54 | $137 | $360 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
52 | $154 | $292 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
51 | $45 | $132 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $136 | $220 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
45 | $113 | $420 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
35 | $19 | $60 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $73 | $241 |
| New patient office visit, complex (60-74 min) | 14 | $174 | $500 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $12 | $95 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
12 | $128 | $345 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,582
Total received (2018-2024)
Avg $1,083/year across 7 years
Top 12% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
329
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,411 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$171 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,156
2023
$1,176
2022
$866
2021
$473
2020
$501
2019
$504
2018
$2,906
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$222
Astellas Pharma US Inc
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Bayer Healthcare Pharmaceuticals Inc.
$90
Lilly USA, LLC
$89
Xeris Pharmaceuticals, Inc.
$68
Alexion Pharmaceuticals, Inc.
$62
Dexcom, Inc.
$45
Abbott Laboratories
$45
Novo Nordisk Inc
$38
Radius Health, Inc.
$36
ABBVIE INC.
$35
Novartis Pharmaceuticals Corporation
$31
Kyowa Kirin, Inc.
$28
Corcept Therapeutics
$28
SANOFI-AVENTIS U.S. LLC
$27
Mannkind Corporation
$20
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 43.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,084
Amgen Inc.
$657
AstraZeneca Pharmaceuticals LP
$600
SANOFI-AVENTIS U.S. LLC
$525
Boehringer Ingelheim Pharmaceuticals, Inc.
$449
Lilly USA, LLC
$441
Corcept Therapeutics
$340
MannKind Corporation
$268
Dexcom, Inc.
$245
Bayer Healthcare Pharmaceuticals Inc.
$240
Medtronic, Inc.
$240
Alexion Pharmaceuticals, Inc.
$171
Abbott Laboratories
$167
GlaxoSmithKline, LLC.
$159
Xeris Pharmaceuticals, Inc.
$157
Astellas Pharma US Inc
$156
Medtronic MiniMed, Inc.
$133
Mannkind Corporation
$126
Teva Pharmaceuticals USA, Inc.
$118
Radius Health, Inc.
$111
Novartis Pharmaceuticals Corporation
$94
Insulet Corporation
$90
Merck Sharp & Dohme Corporation
$90
Horizon Therapeutics plc
$81
Shire North American Group Inc
$73
IBSA Pharma Inc.
$69
iRhythm Technologies, Inc.
$66
Endo Pharmaceuticals Inc.
$66
Bayer HealthCare Pharmaceuticals Inc.
$62
Regeneron Healthcare Solutions, Inc.
$57
Tandem Diabetes Care, Inc.
$47
Octapharma USA, Inc.
$38
AbbVie, Inc.
$37
Vertical Pharmaceuticals, LLC
$35
ABBVIE INC.
$35
Averitas Pharma Inc.
$31
Antares Pharma, Inc.
$31
Kyowa Kirin, Inc.
$28
Strongbridge US INC.
$28
Ferring Pharmaceuticals Inc.
$28
Ascendis Pharma Inc
$26
PFIZER INC.
$20
GRT US Holding, Inc.
$19
CeQur Corporation
$18
Companion Medical, Inc.
$16
Genentech USA, Inc.
$12
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BREO · BREZTRI · BYDUREON · CINQAIR · CUTAQUIG · CUVITRU · CeQur Simplicity · Crysvita · DIVIGEL · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 3 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · JANUMET XR · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · MACRILEN · MINIMED 780G · MOUNJARO · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NUCALA · NovoLog · OTREXUP · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · Qutenza · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · Veozah · Victoza · Wegovy · ZIO Patch · ZOMACTON · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,666
Per 100K population
143.4
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - CONCORD CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhat is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhat experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Bhat performed 7,440 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhat receive payments from pharmaceutical companies?
Yes. Dr. Bhat received a total of $7,582 from 46 companies across 329 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhat's costs compare to other internal medicine physicians in Concord?
Dr. Bhat's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Concord
Browse internal medicine physicians in Concord ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology